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Tuesday, February 10, 2015 417amGlu stoichiometry and to explore how these receptors cooperatively activate
in response to ligand binding.We first used single molecule fluorescence photo-
bleaching in live Xenopus oocytes and in receptors immobilized from mamma-
lian cell lysate to map the dimer interfaces of homo and heterodimers. This
work was complemented by experiments that use a covalently attached photo-
switchable tethered ligand (PTL) that works as an agonist to analyze the coop-
erativity that arises from ligand binding to one or both subunits within a dimer.
Finally, intersubunit FRET was used to analyze the conformational changes of
mGluRs in order to gain an integrative view of receptor assembly, structural
dynamics, and activation.
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Glycan-protein interactions are emerging as important modulators of mem-
brane protein organization and dynamics, regulating multiple cellular func-
tions. In particular, it has been postulated that glycan-mediated interactions
regulate surface residence time of glycoproteins and endocytosis. How this
precisely occurs is poorly understood. We applied a combination of super-
resolution nanoscopy and single molecule-based approaches to study the
role of glycan-based interactions on the dynamics of the glycosylated pathogen
recognition receptor DC-SIGN, at the nano- and micrometer scale. We find
that cell surface glycan-mediated interactions do not influence the nanoscale
lateral organization of DC-SIGN in nanoclusters but restrict the mobility of
the receptor to distinct micron-size membrane regions. These meso-scale re-
gions are in turn enriched by the endocytic protein clathrin, thereby dynami-
cally promoting DC-SIGN transient nano-scale arrest and interaction with
clathrin. Disruption of glycan-based connectivity leads to larger mem-
brane exploration, reduced clathrin interaction and compromised clathrin-
dependent internalization of virus-like particles. Therefore, our work uncovers
a novel mechanism through which glycan-protein interactions act as decision-
makers in fine-tuning membrane-related functions by dynamically coupling
micro- and nanoscale receptor lateral mobility, thus adding a new layer
of regulation to the hierarchical spatiotemporal organization of the cell
membrane.
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The initial arrest of platelets at a wound site requires the binding of glycopro-
tein Ib-IX-V complex (GPIb-IX-V) to the extracellular matrix protein von
Willebrand factor (VWF). Increasing forces on these bonds increases the
bond lifetime, known as a catch bond. Recently, we have shown that platelets
are able to transmit cytoskeletal forces through the GPIba subunit of GPIb-IX-
V, which binds to the A1 domain of VWF. This provides an internal force on
the bond to maintain adhesion in the absence of external forces. Integrin
engagement and force transmission are known to require receptor clustering.
We therefore investigate whether the clustering of GPIb-IX-V receptor is
needed for the transmission of cytoskeletal forces to VWF. We first examined
whether GPIb-IX-V clusters formed in spreading platelets. GPIba-positive
punctate structures were visualized by confocal microscopy and correlated
with dark regions imaged using interference reflection microscopy (IRM),
indicating that GPIb-IX-V forms adhesive contacts that are similar in size
to integrin-related focal adhesions in platelets. To investigate the effect of
ligand density on platelet spreading, we prepared molecularly-defined adhe-
sive ligand spots, which were separated 28 or 108 nm apart by nonadhesive
regions using self-assembling gold nanoparticles. These nanoparticles were
coated with A1 domain of VWF. When seeded on nanoparticles with 28 nm
spacing, platelets appeared well-spread and formed punctate adhesions. How-
ever, when seeded on 108 nm spacing, platelet adhesion was significantlyreduced and those platelets that did adhere spread poorly. These findings
demonstrate that an upper limit for ligand density exists where platelet adhe-
sion and spreading are impeded. Investigating the effects of ligand spacing
will facilitate an understanding of GPIba clustering in platelet adhesion and
spreading, thus providing insight into thrombotic diseases and congenital
bleeding disorders.
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There is increasing evidence suggesting the importance of IL-6 in oncogenesis:
it stimulates tumor cells proliferation and promotes cell survival through the
inhibition of apoptosis. IL-6 acts on a receptor complex consisting of the
cytokine-specific IL-6Ra chain and the signal-transducing gp130 subunit.
Binding of IL-6 to IL-6Ra induces dimerization of gp130 which initiates
multiple signaling cascades, including STAT3 activation.
Chelidonine, the major alkaloid component of C. majus, provokes cell death in
a variety of tumor cells, possibly through the antiapoptotic Bcl-2 protein.
Expression of Bcl-2 is upregulated by STAT3 activation, which is thought to
be responsible for IL-6-mediated survival of tumor cells.
Herein we aimed to study the effect of chelidonine on the viability of human
uveal melanoma cells as wells as its interference with the IL-6R/STAT3
signaling pathway.
Antiproliferative and cell death-inducing effects of chelidonine were assessed
by flow cytometry. The apoptotic potential of chelidonine was followed by
DNA fragmentation and PI exclusion/annexin V binding assays. Expression
of STAT3, Bcl-2 and IL-6Ra and the efficiency of STAT3 activation was
also studied by flow cytometry.
Combined analysis of cell death experiments revealed chelidonine-induced
apoptosis of UM cells. Moreover, alkaloid treatment also resulted in necrotic
cell death.
Pretreatment of cells even with sublethal doses of chelidonine led to the appear-
ance of a subpopulation with abrogated STAT3 activation upon IL-6 stimula-
tion and modified Bcl-2 expression levels. We detected cells with reduced
expression of STAT3 and IL-6Ra; however, the amount of these cells was
significantly lower than that of cells with abolished STAT3 signaling.
According to our results chelidonine exerts its effect via a STAT3-dependent
mechanism. Our findings imply the possible use of chelidonine in cancer
therapy: it can either provoke cell death or weaken the antiapoptotic machinery
of tumor cells fueled by IL-6.
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Insulin is the blood glucose-lowering hormone essential for glucose homeosta-
sis. b-Cells secrete insulin in pulses in response to glucose. Loss of the oscil-
latory nature of insulin secretion is associated with the development of type
II diabetes. Calcium is the most important trigger of insulin release even though
the exact mechanism of insulin secretion regulation by calcium is elusive.
Arachidonic acid (AA) is an essential signalling molecule involved in regula-
tion of physiological functions of many cell types. In insulin secreting pancre-
atic b-cells AA was shown to modulate calcium levels and as result to trigger
insulin secretion. However, the exact interplay between AA signalling and in-
sulin secretion is still a matter of speculation. In the present work we investi-
gated the difference of AA action at the internal membranes (IMs) and the
plasma membrane (PM) of b-cells. To perform this study, we developed a
caging group which permits localization, visualization and quantitative photo-
release of AA exclusively on the PM of living cells. We applied it in combina-
tion with a previously reported caging group used to release AA on the IMs. We
found that the release of AA on the PM and the IMs leads to a significantly
different modulation of intracellular calcium dynamics. Uncaging of AA on
the PM induces calcium oscillations in non-oscillating cells and increases the
duration of calcium transients in oscillating cells, leading to overall higher cal-
cium levels. Release of AA on the IM results in transiently or permanently
diminished calcium oscillations in b-cells and lower average calcium levels.
We attribute the observed effects to direct action of AA on Arachidonic acid
Regulated Calcium (ARC) channels localized on the PM and potentially a
negative feedback mechanism triggered by higher levels of AA at the internal
membranes.
